Please assess the completion status of the following clinical trial:

Trial Title: The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Individual with diabetes mellitus type I or type II mild to moderate non-proliferative diabetic retinopathy which will be based on ETDRS grading scale~* Patient must be 18 years and older~Exclusion Criteria:~* Patients with severe non-proliferative or proliferative diabetic retinopathy~* Patients with macular edema~* Eye diseases that may interfere with visualization of the fundus such as preretinal hemorrhage, cataract, vitreous hemorrhage~* Patient that has undergone any type of interventional therapy for diabetic retinopathy (Such as laser photocoagulation, vitrectomy)~* Amblyopia~* Glaucoma~* Patient with cataract surgery within a period of 4 months~* Patients with other retinal diseases~* Patients on chronic administration of alpha lipoic acid~* Known intolerance/hypersensitivity to alpha lipoic acid~* Patient with history of dialysis in cases of renal insufficiency and history of kidney transplantation~* Malignancies or life threatening diseases as determined by the investigators~* Current history of drug or alcohol abuse~* Pregnant and breast feeding women~* Cognitively impaired patients~* Participation in a clinical trial within the last 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Alpha Lipoic Acid Assignment Group (Type: EXPERIMENTAL): Alpha lipoic acid assignment group will follow routine care and receive 600 mg oral administration of lipoic acid daily.
- Alpha Lipoic Acid Control Group (Type: NO_INTERVENTION): The control group will follow routine care alone.

Based on this trial design, predict the completion outcome and termination type (if applicable).